Low affinity GPCRs for metabolic intermediates: challenges for pharmacologists.
about
Expression, regulation and putative nutrient-sensing function of taste GPCRs in the heart.GPCR activation: protonation and membrane potentialDrugs or diet?--Developing novel therapeutic strategies targeting the free fatty acid family of GPCRsCD36- and GPR120-mediated Ca²⁺ signaling in human taste bud cells mediates differential responses to fatty acids and is altered in obese mice.Minireview: The effects of species ortholog and SNP variation on receptors for free fatty acids.Metalloprotease cleavage of the N terminus of the orphan G protein-coupled receptor GPR37L1 reduces its constitutive activity.Neurosteroid regulation of GABA receptors: A role in catamenial epilepsy
P2860
Q34734229-4553A221-B2EA-4500-B96C-98A9F248D40FQ36922998-AB776E39-4032-466B-B2EF-000D644DE729Q37237145-36CE266A-D1AC-4BC1-8C4B-F4C9141F61B9Q37691783-7C330E74-4CA7-41B4-86CC-22E0492E1EE2Q38107811-CDDB5DBA-BB7A-4AC3-80FF-FAED8A950BACQ39855336-B8FBFB4F-3E42-4C21-94EF-53F33D3697B6Q56383791-217A897B-4B11-4918-9E7E-7D66275E84CD
P2860
Low affinity GPCRs for metabolic intermediates: challenges for pharmacologists.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Low affinity GPCRs for metabolic intermediates: challenges for pharmacologists.
@en
type
label
Low affinity GPCRs for metabolic intermediates: challenges for pharmacologists.
@en
prefLabel
Low affinity GPCRs for metabolic intermediates: challenges for pharmacologists.
@en
P2860
P356
P1476
Low affinity GPCRs for metabolic intermediates: challenges for pharmacologists
@en
P2093
Nicola J Smith
P2860
P356
10.3389/FENDO.2012.00001
P577
2012-01-13T00:00:00Z